Literature DB >> 7991042

Outcome and prognostic determinants in the hemolytic uremic syndrome of children.

B Tönshoff1, A Sammet, I Sanden, O Mehls, R Waldherr, K Schärer.   

Abstract

The late outcome in 89 children with the hemolytic-uremic syndrome (HUS) observed from 1971 to 1988 was analyzed up to 17 years after onset in relationship to various clinical and pathologic features at the onset of the disease. In the first 3 months after onset (acute phase) 69% of all children needed dialysis therapy. Fifteen children died, 9 during the acute phase and 6 subsequently. All surviving patients except 7 were reexamined and divided into five prognostic categories: recovery, residual renal symptoms with normal kidney function, moderate renal insufficiency, preterminal chronic renal failure (CRF) and end-stage renal disease (ESRD). The rate of recovery calculated by the life table method increased from 35% after 10 years in 1971-1979 to 68% in 1980-1988 (p < 0.001); it was lower in infants than in older children (44 vs. 63%; nonsignificant). Children with atypical HUS experienced more often preterminal CRF, ESRD or death than those with a typical (postenteropathic) form (33 vs. 17%; p < 0.05). If oliguria lasted < 7 days, 74% of patients recovered after 10 years versus 13% in the case of oliguria > 14 days or anuria > 7 days (p < 0.0005). The rate of recovery was also significantly smaller with the duration of dialysis treatment > 7 days, central nervous system involvement and requirement for antihypertensive therapy. In the entire series 7 patients developed preterminal CRF and 5 ESRD. Of 27 cases serially followed for 5-10 years after onset, a stable course was noted in 16, a subsequent improvement in 8 and deterioration in 3 leading to ESRD in 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7991042     DOI: 10.1159/000188221

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  16 in total

1.  Atypical hemolytic uremic syndrome associated with group A beta hemolytic streptococcus.

Authors:  Bilal Yildiz; Nurdan Kural; Coskun Yarar
Journal:  Pediatr Nephrol       Date:  2004-06-16       Impact factor: 3.714

2.  Long-term investigation of kidney ultrasound in cases of hemolytic uremic syndrome in children.

Authors:  Thi Thanh Tam Bui; Heiko Billing; Abdulsattar Alrajab; Elke Wühl; Jens-Peter Schenk
Journal:  J Med Ultrason (2001)       Date:  2013-10-22       Impact factor: 1.314

3.  Atypical hemolytic-uremic syndrome (HUS) with recovery after a long-lasting anuria: a case report.

Authors:  H Georgaki-Angelaki; N Stergiou; A Kapogiannis; I Orfanou; B Grapsa; E Roma
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 4.  Heterogeneity of atypical haemolytic uraemic syndromes.

Authors:  T J Neuhaus; S Calonder; E P Leumann
Journal:  Arch Dis Child       Date:  1997-06       Impact factor: 3.791

5.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

6.  Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome.

Authors:  Laura De Petris; Alessandra Gianviti; Ugo Giordano; Armando Calzolari; Alberto E Tozzi; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

7.  Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.

Authors:  Martin Kreuzer; Laura Sollmann; Stephan Ruben; Maren Leifheit-Nestler; Dagmar-Christiane Fischer; Lars Pape; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2017-02-08       Impact factor: 3.714

Review 8.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

Review 9.  Pathogenesis of thrombotic microangiopathies.

Authors:  X Long Zheng; J Evan Sadler
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

10.  Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

Authors:  Robert S Oakes; Justin K Kirkham; Justin K Kirkhamm; Raoul D Nelson; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2008-05-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.